Story thread · 2 reports / 2 sources
Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma
phys.org · 4d
Glioblastoma is one of the most aggressive and treatment-resistant brain cancers known to medicine, carrying a median survival of just 12–15 months, even with the best available care.
First report: Injectable nanodevices could provide effective treatment for drug-resistant glioblastoma — news.mit.edu, 5d
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.